Skip to Main Content (Press Enter)
×
Home
People
Organizations
Expertise & Skills
Outputs
Jobs
Degrees
Courses
Third Mission
Equipment
IT
EN
☰
Expertise & Skills
|
Expertise & Skills
unibs.it
IT
EN
×
Home
People
Organizations
Expertise & Skills
Outputs
Jobs
Degrees
Courses
Third Mission
Equipment
☰
Outputs
THE LANCET DIABETES & ENDOCRINOLOGY
Journal
Identifier:
E226590
ISSN:
2213-8587
Overview
Overview
Outputs (8)
2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial
Academic Article
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Academic Article
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment
Academic Article
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Academic Article
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants
Academic Article
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
Academic Article
Growth hormone replacement therapy and fracture risk
Academic Article
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
Academic Article
No Results Found